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http://www.biomedcentral.com/1471-2482/13/23RESEARCH ARTICLE Open AccessPancreato-jejunostomy versus hand-sewn closure
of the pancreatic stump to prevent pancreatic
fistula after distal pancreatectomy:
a retrospective analysis
Roberto L Meniconi*, Roberto Caronna, Dario Borreca, Monica Schiratti and Piero ChirlettiAbstract
Background: Different methods of pancreatic stump closure after distal pancreatectomy (DP) have been described
to decrease the incidence of pancreatic fistula (PF) which still represents one of the most common complications in
pancreatic surgery. We retrospectively compared the pancreato-jejunostomy technique with the hand-sewn closure
of the pancreatic stump after DP, and analyzed clinical outcomes between the two groups, focusing on PF rate.
Methods: Thirty-six patients undergoing open DP at our institution between May 2005 and December 2011 were
included. They were divided in two groups depending on pancreatic remnant management: in 24 cases the stump
was closed by hand-sewn suture (Group A), while in 12 earlier cases a pancreato-jejunostomy was performed
(Group B). We analyzed postoperative data in terms of mortality, morbidity and length of hospital stay between the
two groups.
Results: PF occurred in 7 of 24 (29.1%) cases of group A (control group) compared to zero fistula rate in group B
(anastomosis group) (p=0.005). Operative time was significantly higher in the anastomosis group (p=0.024).
Mortality rate was 0% in both groups. Other postoperative outcomes such as hemorrhages, infections, medical
complications and length of hospital stay were not significant between the two groups.
Conclusion: Despite a higher operative time, the pancreato-jejunostomy after DP seems to be related to a lower
incidence of PF compared to the hand-sewn closure of the pancreatic remnant.
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Distal pancreatectomy (DP) is a surgical procedure
performed mostly for benign, borderline or malignant tu-
mors of the body and tail of the pancreas [1]. It is also in-
dicated for the treatment of chronic pancreatitis [2].
Depending on the disease, it could be associated to splen-
ectomy, lymphadenectomy or multivisceral resections.
Despite this operation is performed with relatively low
morbidity and mortality rates in high-volume centers, the
leakage from pancreatic stump after DP remains a prob-
lem, determining a pancreatic fistula (PF) in 5-30% of
cases according to recent papers [1,3,4] and contributing* Correspondence: robmeni@tiscali.it
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reproduction in any medium, provided the orto increased morbidity and overall costs. Different tech-
niques of pancreatic stump closure have been described to
reduce the incidence of PF, such as stapler transection,
pancreatic duct occlusion by fibrin-glue sealant, serosal or
artificial patches, ultrasonic scalpel or radiofrequency dis-
sector [1,5-10], but none has proved to be the most effect-
ive in preventing PF. Up till now, few authors described
the drainage of the pancreatic stump into a jejunal loop
[5,11-13] and a recent study demonstrated a significant
decrease of pancreatic leakage by performing a Roux-en-Y
pancreato-jejunostomy [14]. The aim of this study is to
confirm the efficacy of the pancreato-jejunostomy in redu-
cing pancreatic fistula rate after DP, compared to simple
hand-sewn closure of the pancreatic remnant.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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A total of 36 patients (14 males and 22 females) undergo-
ing DP between May 2005 and December 2011 were in-
cluded in this study and retrospectively analyzed. All
patients were studied preoperatively by contrast-enhanced
computed tomography or magnetic resonance imaging. In-
dications for surgery were benign, borderline or malignant
tumors, chronic pancreatitis and pancreatic pseudocysts.
Surgical operation consisted in an en-bloc resection of the
pancreas tail, eventually extended to the body, associated
with splenectomy or other organs resection if needed. In
all cases an open approach was performed by a single sur-
geon. Most of pancreato-jejunostomies were performed
not consecutively in the first period of this study, between
May 2005 and October 2008, depending on the surgeon
preference. From November 2008 all patients undergoing
DP were enrolled in another survey in which the pancre-
atic stump was closed by direct suture with the technique
described below. Then we retrospectively observed and an-
alyzed different outcomes between the two techniques.
Patients were divided in two groups on the basis of pan-
creatic stump management. In the first group (Group A),
after pancreatic resection, the stump closure was accom-
plished by ligating the main pancreatic duct with non-
resorbable Z-shaped suture and the cut margin was over
sewn a traumatically by U-shaped stitches using non-
resorbable material (TiCronW, Covidien, Mansfield, MA,
USA) supported by PTFE (Teflon) pledgets used as but-
tress for the suture (Figure 1). In the second group (Group
B), the main pancreatic duct was closed with the same
technique described above and the pancreatic stump was
finally invaginated into a jejunal loop performing a Roux-
en-Y end-to-end pancreato-jejunostomy. The anastomosis
was completed by a capsule-to-seromuscular single layer
suture with non-resorbable interrupted stitches (Figure 2).Figure 1 Hand-sewn closure of the pancreatic remnant.
The pancreatic remnant is closed using PTFE pledget-supported
interrupted stitches of non-resorbable material.A drain was placed intraoperatively in all cases near the
anastomosis or the pancreatic stump. All patients received
a short-term antibiotic prophylaxis.
Intravenous fluids, octreotide (3 × 0.1 mg s.c., daily for
5–7 days) and proton pump inhibitors (omeprazole, 40
mg i.v., daily) were administrated postoperatively. Oral
feeding was generally resumed depending on gastrointes-
tinal function. Drainage volume and amylase concentra-
tion of drained fluid were measured and registered in the
1st, 3rd, 5th and 7th postoperative day as well as blood tests.
Patient demographics, operation data, post-operative
morbidity, mortality rate and length of hospital stay were
analyzed and compared between the two groups. PF was
defined as a drain output of any measurable volume of
fluid on or after postoperative day 3 with an amylase
content greater than 3 times the upper normal serum
value, in accordance to the International Study Group of
Pancreatic Fistula (ISGPF) [15]. PF was also classified
into three grades (A,B,C) depending on clinical impact
(none, moderate and severe, respectively), according to
the ISGPF classification. The pancreatic texture was de-
fined as “fibrotic” or “non-fibrotic” depending on histo-
logical findings of the specimens: presence of perilobular
fibrosis, chronic inflammatory reactions with ductal dilata-
tions, atrophy of the acinar cells. The main pancreatic duct
(MPD) was also defined as “small” or “large” according to
the diameter < or > 3 mm, respectively. Postoperative
hemorrhage (PH) was defined and classified into three dif-
ferent grades (A,B,C), according to the International Study
Group of Pancreatic Surgery definition (ISGPS) [16]. Mor-
tality was considered as any death occurred intraoperatively
or during the hospital stay.
Statistical analysis was performed using χ2 test and
Student’s t-test. Differences were considered significant
at p-value <0.05.Figure 2 Roux-en-Y end-to-end pancreato-jejunostomy.
The pancreatic stump is invaginated into the jejunal loop and a
capsule-to-seromuscular suture is performed using non-resorbable
interrupted stitches.
Table 2 Operation data
Data Group A Group B P-
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data and the human research ethics committee of our insti-
tution stated to exempt it from formal ethical review
according to the ethical principles laid forth by the Helsinki
Declaration. Written consent of patients was not sought.
No identifying information was recorded by the authors.
Results
Between May 2005 and December 2011, thirty-six patients
underwent DP at our institution. All patients were divided
retrospectively in two groups depending on pancreatic
stump management: Group A (control group) comprised
24 patients with a mean age of 53.6 years (range 25–75
years) in which the pancreatic remnant was closed by an
hand-sewn technique; Group B (anastomosis group)
comprised 12 patients with a mean age of 50.5 years
(range 27–67 years) in which a pancreato-jejunostomy
was performed. Patients demographics of two groups were
compared and well-matched as reported in Table 1.
Indications for surgical resection were pancreatic tumors
in 30 patients (20 of group A, 10 of group B), chronic pan-
creatitis in 3 patients (2 of group A and 1 of group B), and
pancreatic pseudocysts in 3 patients (2 of group A, 1 of
group B). Splenectomy was performed in 22 cases (61,1%),
while a cholecystectomy was carried out in 4 patients with
gallstones; two cases required a left nephrectomy due to a
locally advanced disease and in one case a portal vein
resection with graft reconstruction was performed for
suspicion of neoplastic venous infiltration. Mean operative
time was significantly higher in the anastomosis group
(192 min) compared to the control group (161 min)
(p=0.024). 10 patients (83,6%) of the anastomosis group
had a non-fibrotic pancreas compared to 18 patients
(75%) of the control group (p=0.584); a small MPD wasTable 1 Patient demographics
Data Group A Group B P-
value(control; n=24) (anastomosis; n=12)
Age (years) 53.6 (25–72) 50.5 (27–67) 0.473
Gender 0.640
- Male 10 4
- Female 14 8
BMI 29.6 (24.1-40.5) 28.9 (22.5-35.4) 0.681
Tobacco use 11 5 0.819
Alcohol abuse 6 4 0.611
DM 8 5 0.635
HTN 11 5 0.819
COPD 1 1 0.619
CRF 1 0 0.487
All quantitative values are given as mean (range).
BMI Body Mass Index, DM diabetes mellitus, HTN arterial hypertension, COPD
chronic obstructive pulmonary disease, CRF chronic renal failure.found in 15 patients of group A and in 8 patents of group
B (p=0.622). All operative data are summarized in Table 2.
Food oral intake depended on recovery of gastrointes-
tinal motility and started generally from the third post-
operative day. Abdominal drains were removed after a
mean duration of 5 days.
PF rate was significantly higher in the group A (control)
in which pancreatic leakage occurred in 7 patients (29.1%)
compared to group B (anastomosis) where no patient had
a PF (p=0.005). They were all pure fistulas, three of grade
A and four of grade B, while no grade C fistula occurred.
No correlation between PF development and histological
findings of the specimens was found. All patients with a
grade A fistula were treated conservatively by removing
gradually the drain. Patients who had a grade B fistula
received total parenteral nutrition (TPN), continuous
intravenous somatostatin (6 mg, daily) and antibiotics. In
two patients an amylase-rich intra-abdominal collection
occurred and was drained by a percutaneous drainage
with no severe clinical impact in both cases: this was the
reason for classifying them as Grade B (rather than grade
C) PF according to recent revisions of the ISGPF- Pancreatic
pseudocyst
2 1
- Neuroendocrine 10 5
Pancreatic texture: 0.584
- Soft 18 10
- Fibrous 6 2
Main pancreatic duct size: 0.622
- Small 15 8
- Larger 9 4
Other surgical procedures:
- Splenectomy 14 8 0.640
- Nephrectomy 2 0 0.162
- Cholecystectomya 3 1 0.717
- Other proceduresb 1 0 0.487
Operative time 161 (99–245 min) 192 (155–240 min) 0.024
Quantitative values are given as mean (range).
aAll these patients had gallstones.
bIn this case a vascular resection with graft reconstruction was performed.
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drains in situ and observed in the outpatient setting. No
patient was readmitted.
Other post-operative outcomes were not significant
between the two groups as shown in Table 3.
Postoperative hemorrhage (PH) occurred in two patients
of the control group. One patient with normal amylase
values from the drain, had a grade C PH due to the rup-
ture of a pseudoaneurysm of the splenic artery after a
spleen-preserving DP, which required an angiographic
embolization. In the other case the origin of the bleeding
was from the retroperitoneal tissue in the spleen site after
a DP associated to splenectomy: it was a grade B PH
which was treated conservatively by fluids and blood
transfusions.
The mean length of hospital stay was higher in group
A compared to group B (9.5 vs 8.1 days, respectively),
but it was not significant (p=0.077).
Mortality rate was zero in both groups.Table 3 Post-operative outcomes
Data Group A Group B P-








- Hemorrhageb 1 (4.1%) 1 (8.3%) 0.162
Grade A 0 0
Grade B 0 1








- Cardiac 4 1 0.509
- Pulmonary 1 0 0.487
- Renal 0 1 0.487
- Other 1 1 0.619
Length of hospital
stay
9.5 (6–14 days) 8.1 (6–12 days) 0.077
Mortality 0 0
Quantitative values are given as mean (range).
aAccording to the ISGPF classification [15].
bAccording to the ISGPS classification [16].
cDefined as non-surgical post-operative complications.Discussion
DP is a surgical procedure performed with relatively low
morbidity and mortality rates in high-volume centers. Sur-
gical outcomes and long-term results have improved
widely during the last two decades [18]. However, PF is
still the most frequent complication after DP, with an inci-
dence of 5-30% according to the literature [1,3-7], origin-
ating from the cut margin of the pancreatic remnant and
contributing significantly to morbidity, length of hospital
stay and overall costs.
Several approaches to pancreatic stump closure have
been described in literature, but none has proved to be
the most effective to prevent PF. In a large series by
Ferrone et al. [6] different closure techniques were com-
pared as hand-sewn closure, stapler with or without
staple line reinforcement, use of free falciform patches
and pancreatic duct ligation, but no significant difference
in PF rate was found between groups. These data have
been confirmed recently by the European multicentric
DISPACT trial [7] in which two groups of patients were
randomly assigned to stapler or hand-sewn closure of pan-
creatic remnant with no difference found in PF incidence.
The use of artificial patches on the cut margin or the in-
jection of fibrin-glue sealant into the pancreatic duct have
also been described [8,9] with good results but larger
series are required to demonstrate their efficacy. Recently
a new method of stump closure by radiofrequency dis-
sector has been reported with low PF rate, but further pro-
spective studies are needed [10].
As shown in Table 4, few authors described retrospect-
ively their experience of draining the pancreatic stump
into a jejunal loop and small series are reported [5,11,12].
More recently, Wagner et al. [14], demonstrated the effi-
cacy of this method comparing the hand-sewn closure to
the Roux-en-Y end-to-side pancreato-jejunostomy: they
found a zero PF rate in the anastomosis group compared
to 20% of PF incidence without anastomosis. However, in
that study PF was neither defined nor classified into three
grades of severity according to the ISGPF classification
[15]. We found same significant results in our series, but
with two significant differences: we performed a different
type of anastomosis (end-to-end pancreato-jejunostomy)
and defined strictly the PF in accordance to the ISGPF
classification. The rationale of these encouraging results is
based on the assumption that after pancreatic resection
the main pancreatic duct is usually visualized and ligated
while secondary branches remain always patent owing to
their small dimension and this may be a source of pancre-
atic leakage. This is confirmed by most Authors who
reported unchanged PF rates despite they routinely ligated
the main pancreatic duct [4,6]. For this reason we mini-
mized the pancreatic secretion by closing the main pan-
creatic duct while secondary branches were drained by
dunking the stump into a jejunal loop: in our opinion the
Table 4 Case series reporting pancreato-jejunostomy and other stump closure techniques after distal pancreatectomy
Authors Study design Variable Sample size n (%) PF rate (%) P-value
Lillemoe et al. [1] Retrospective Pancreato-jejunostomy 10 (4%) NAa NA
Hand-sewn closure 204 (87%) NA
Stapled 11 (5%) NA
Both 10 (4%) NA
Kleeff et al. [11] Retrospective Pancreatico-jejunostomy 24 (8%) 0 0.03
Hand-sewn closure 97 (32.1%) 9.3
Stapled 145 (48%) 15.9
Serosal patches 36 (11.9%) 8.3
Adam et al. [12] Retrospective Pancreatico-jejunostomy 27 (65.8%) 7 NS
Hand-sewn closure 14 (34.2%) 29
Wagner et al. [14] Retrospective Pancreato-jejunostomy 23 (53.5%) 0 0.04
Hand-sewn closure 20 (46.5%) 20
NA not available, NS not significant, PF pancreatic fistula.
aIn this large series the authors reported a total PF rate of 5% with no comparison between methods of stump closure.
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complete drainage of pancreatic juice as the stump is en-
tirely enveloped into the jejunum with this technique
compared to the end-to-side anastomosis performed by
Wagner et al. [14]. This may explain the low PF rate in
our patients. On the other hand, it has to be considered
that a pancreatic leakage following small bowel anasto-
mosis could result in a clinically relevant PF (grade B/C
PF) and in potentially more hazardous complications (e.g.
activation of pancreatic enzymes, bacterial contamination)
than leakage after hand-sewn closure of the pancreatic
stump. In our series no patient experienced any complica-
tion related to the anastomosis, but the statistical power of
this study is surely limited by the small sample size of
patients, especially for the anastomosis group. For these
reasons, at the end of this study, in our institution it cur-
rently depends on the surgeon preference to perform the
pancreato-jejunostomy especially if it can be carried out
safely in selected patients considering the higher operation
time and the potential risks of this technique, as described
above, despite of its promising results. Moreover there is a
clear tendency to perform this operation with a laparo-
scopic approach, thus some surgeons would prefer any-
how the simple closure by laparoscopic stapler transection
rather than open DP with pancreato-jejunostomy.
Besides different techniques of stump closure, other fac-
tors have been considered in PF development after DP:
the texture of the pancreatic gland, the use of somatostatin
and its analogues (octreotide) and the association with
splenectomy. Some studies reported that a non-fibrotic
(or soft) pancreas with a small MPD is related to an higher
PF rate [19,20]: in our study most cases of both groups
had a non-fibrotic pancreas and a small MPD but no PF
occurred in the anastomosis groups. The role of somato-
statin and its analogues in reducing PF rates afterpancreatic surgery is still debated and its use remains con-
troversial [20-24]. Despite a recent Cochrane meta-analysis
[22] concluded that the prophylactic use of somatostatin
cannot be recommended, other surveys demonstrated its
efficacy as consequence of pancreatic exocrine function in-
hibition after pancreatic surgery [23,24]. On the basis of
these studies and in accordance to a more recent meta-
analysis [25], we decided to administrate somatostatin ana-
logues prophylactically to all patients, even if most studies
cited about its efficacy involved patients undergoing prox-
imal pancreatic resections. The impact of splenectomy on
PF development after DP is still controversial [6,26] and we
did not find any difference between patients undergoing
DP with or without splenectomy.
The operative time was significantly different between
the two groups with a mean difference of 31 min, but it
was not related to PF development or other post-
operative complications.
The length of hospital stay depended primarily on the
presence of non-surgical complications.Conclusion
In this study we observed the efficacy of the pancreato-
jejunostomy to prevent PF after DP compared to the
hand-sewn closure of the pancreatic remnant. Despite a
higher operation time, it is a safe operation with low mor-
bidity and no mortality rate. However, these are results of
a retrospective non-randomized analysis of a small group
of patients: larger series are required to confirm these data
and several centers must be involved in prospective
studies.Competing interests
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